Forget Ocugen! Here's a COVID Stock That Could Make You Richer Quicker
It's taken the S&P 500 index 25 years to rise more than 500%. Ocugen (NASDAQ: OCGN) just did it in two weeks.
Many investors have jumped aboard the Ocugen bandwagon after the drugmaker finalized a deal with Bharat Biotech to co-develop COVID-19 vaccine Covaxin for the U.S. market. Some of them have made a boatload of money in a very short period.
But the rapid growth for Ocugen's share price has tapered off now. The moment for raking in enormous profits practically overnight seems to have passed. What should investors who missed the party do now?
Source Fool.com
